Labs / ADME, DMPK & toxicology

Aryastha Life Sciences
Hyderabad, India · aryastha.com
GLP · GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Aryastha Life Sciences provides drug discovery, preclinical development, and manufacturing-related services for pharmaceutical and biotechnology companies. It operates from sites in Hyderabad, Cambridge, and San Diego and supports integrated programs across discovery, DMPK, toxicology, and development. The company also works with patient-derived and iPSC-based platforms for disease and toxicity studies.
Their website has a general contact form; we send your quote request through it.
What they offer
Integrated Drug Discovery (IDD)
Offers integrated services spanning target identification, lead discovery, optimization, and preclinical and clinical development support.
Discovery Chemistry
Provides medicinal chemistry support for compound design, structure-activity relationship work, and preclinical evaluation.
Discovery Biology
Supports biological evaluation for drug discovery and development using established and primary cells.
In Vivo Pharmacology
Provides in vivo pharmacology services as part of the discovery workflow.
Pre-Clinical DMPK
Offers preclinical DMPK services including ADME, pharmacokinetics, bioanalysis, metabolism, and drug-drug interaction studies.
Toxicology
Provides toxicology services, including iPSC-based experimental toxicology platforms.
Drug Product & Formulation
Supports drug product and formulation R&D and development.
Process Chemistry Services
Supports route scouting and process development for drug substance manufacturing.
Patient Derived Primary Cell 2D-Culture
Offers primary screening using cells derived from patient diseased organs to assess compound effectiveness.
Patient Derived Tumor Organoids (PDTO)
Provides patient-derived tumor organoid platforms for discovery and testing.
Patient Derived Tumor Slice Culture (PTSC)
Provides patient-derived tumor slice culture services for drug discovery studies.
iPSC Derived Toxicity Platform (iTox)
Provides human iPSC-based toxicology platforms for cardiac and other toxicity studies.
What they work on
- Modalities
- cell-based models, patient-derived cells, organoids, iPSC-derived models
- Species and models
- human iPSC, patient-derived diseased organ cells, primary cells, established cells, hepatocytes, neuronal origin cells, glial origin cells, pulmonary origin cells, hemato-lymphoid origin cells, Tauopathies (FTD/AD), ALS, Schizophrenia, and 3 more
- Assays and studies
- IC50, IC70, IC90, target engagement, high-throughput screening (HTS), qRT-PCR, RNA seq, LC/MS, ELISA, colorimetric assays, morphology and immunostaining, albumin secretion, and 3 more
- Instruments and platforms
- LC/MS, qRT-PCR
- Scale and capacity
- few milligrams of test molecules, milligrams to kilograms, high/medium throughput
- Therapeutic areas
- oncology, neurodegeneration, pulmonary disorders
- What to send
- few milligrams of test molecules
- Type
- CRDMO
- Sites
- Hyderabad, India · Cambridge, USA · San Diego, USA
- Quality
- Quality by Design (QbD) (process development) · multi-factor authentication (secured IT infrastructure) · role-based access control (IP protection and confidentiality)
- Serves
- India, USA
- Address
- 6725 Mesa Ridge Rd, Suite 260 San Diego, CA 92121
Public records
- Ownership
- ARYASTHA LIFE SCIENCES PRIVATE LIMITED · IN GLEIF
Similar labs. Devsynthesis, Novalix, Laxai Life Science, MedChem Partners
Found in a contract services directory. Listing built from aryastha.com. Work here? Claim this listing.